JPS62169711A - Skin cosmetic - Google Patents
Skin cosmeticInfo
- Publication number
- JPS62169711A JPS62169711A JP1124686A JP1124686A JPS62169711A JP S62169711 A JPS62169711 A JP S62169711A JP 1124686 A JP1124686 A JP 1124686A JP 1124686 A JP1124686 A JP 1124686A JP S62169711 A JPS62169711 A JP S62169711A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- vitamin
- cream
- effect
- preventing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 16
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 239000006071 cream Substances 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 13
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 abstract description 13
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract description 12
- 235000005282 vitamin D3 Nutrition 0.000 abstract description 12
- 239000011647 vitamin D3 Substances 0.000 abstract description 12
- 229940021056 vitamin d3 Drugs 0.000 abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 10
- 239000003872 25-hydroxy-cholecalciferol Substances 0.000 abstract description 5
- 239000004615 ingredient Substances 0.000 abstract description 4
- 239000006210 lotion Substances 0.000 abstract description 4
- JWUBBDSIWDLEOM-UHFFFAOYSA-N 25-Hydroxycholecalciferol Natural products C1CCC2(C)C(C(CCCC(C)(C)O)C)CCC2C1=CC=C1CC(O)CCC1=C JWUBBDSIWDLEOM-UHFFFAOYSA-N 0.000 abstract description 3
- 235000021318 Calcifediol Nutrition 0.000 abstract description 3
- JWUBBDSIWDLEOM-DTOXIADCSA-N calcidiol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)CCC1=C JWUBBDSIWDLEOM-DTOXIADCSA-N 0.000 abstract description 3
- 238000002156 mixing Methods 0.000 abstract description 2
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 abstract 2
- 238000007788 roughening Methods 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 206010013786 Dry skin Diseases 0.000 description 7
- -1 arginine Chemical class 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 235000019441 ethanol Nutrition 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- GMRQFYUYWCNGIN-NKMMMXOESA-N calcitriol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-NKMMMXOESA-N 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 125000004494 ethyl ester group Chemical group 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000036548 skin texture Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- OFHCOWSQAMBJIW-AVJTYSNKSA-N alfacalcidol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C OFHCOWSQAMBJIW-AVJTYSNKSA-N 0.000 description 2
- 229960002535 alfacalcidol Drugs 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 239000004945 silicone rubber Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010005949 Bone cancer Diseases 0.000 description 1
- 206010061728 Bone lesion Diseases 0.000 description 1
- 208000018084 Bone neoplasm Diseases 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- JAWMENYCRQKKJY-UHFFFAOYSA-N [3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-ylmethyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-en-8-yl]-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]methanone Chemical compound N1N=NC=2CN(CCC=21)CC1=NOC2(C1)CCN(CC2)C(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F JAWMENYCRQKKJY-UHFFFAOYSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- ILYCWAKSDCYMBB-OPCMSESCSA-N dihydrotachysterol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1/C[C@@H](O)CC[C@@H]1C ILYCWAKSDCYMBB-OPCMSESCSA-N 0.000 description 1
- 229960000465 dihydrotachysterol Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000036555 skin type Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000003746 surface roughness Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野1
本発明は皮膚化粧料に関し、更に詳しくはビタミンD3
またはその誘導体を配合してなる皮膚化粧料に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application 1] The present invention relates to skin cosmetics, more specifically vitamin D3.
The present invention relates to skin cosmetics containing or a derivative thereof.
[従来の技術]
一般に従来から肌あれの防止および改善を目的とした皮
膚化粧料については、天然物から抽出した原料をはじめ
とし、種々の原材料が今日まで皮膚化粧料に配合されて
使用されてきている。[Prior Art] In general, various raw materials, including raw materials extracted from natural products, have been blended into skin cosmetics and used to date for the purpose of preventing and improving skin roughness. ing.
例えば、ヘチマエキスやプラセンターエキス等の抽出エ
キス、マルメロ等の天然高分子、コラーゲン等の蛋白質
、キチン等の多糖、アルギニン等の単体のアミノ酸、ビ
タミンE等の皮膚賦活剤あるいはグリセリン等の保湿剤
等が肌あれの防止及び改善を目的として盛んに皮膚化粧
料に用いられ、今日に至っている。For example, extracted extracts such as loofah extract and placenta extract, natural polymers such as quince, proteins such as collagen, polysaccharides such as chitin, single amino acids such as arginine, skin activators such as vitamin E, or moisturizers such as glycerin. etc. are widely used in skin cosmetics for the purpose of preventing and improving rough skin, and have continued to this day.
しかしながら、これ等従来の肌あれの防止及び改善に用
いられてきている物質は、顔面皮膚の皮脂量や水分が少
ないことに起因する肌あれの防止及び改善を対象にして
使用されており、最近の論文(Development
of a 5cientific Methodfo
r C1assification of Facia
l 5kin Types。However, these substances that have been conventionally used to prevent and improve skin roughness are being used to prevent and improve skin roughness caused by a low amount of sebum and moisture in the facial skin, and have recently been used to prevent and improve rough skin. Papers (Development
of a 5 scientific method
rC1assification of Facia
l 5kin Types.
Hlroko Kumagai et at:X1ll
Congreso In−ternaciona
l de la I 、 F、 S、 C,C,vo
l。Hlroko Kumagai et at:X1ll
Congreso Internaciona
l de la I, F, S, C, C, vo
l.
1〜19.1984)で明らかになっている別種の肌あ
れ、つまり皮脂量が多く皮丘皮溝が不鮮明で落屑がみら
れるようなタイプの肌あれの防止及び改善には全く効果
は認められず、従って広範囲のタイプの皮膚の正常化に
対して、充分な効果を期待することは全くできないとい
う欠点を有していた。1-19, 1984), it has no effect on preventing or improving a different type of skin roughness, one in which there is a large amount of sebum, the skin mounds and grooves are unclear, and scaling is observed. Therefore, it has the disadvantage that it cannot be expected to have a sufficient effect on normalizing a wide range of skin types.
[発明が解決しようとする問題点]
そこで、本発明者等は、このような実情に鑑みあらゆる
種類の肌あれの防止及び改善に対して効果を有し、更に
安全性・安定性の面からも満足できる物質を得るべく鋭
意研究を重ねた結果、ビタミンD3およびその誘導体か
らなる群から選ばれた一種又は二種以上を配合すると、
あらゆる種類の肌あれの防止及び改善に対して極めて有
用であることを見出し、本発明を完成するに至った。[Problems to be Solved by the Invention] In view of these circumstances, the present inventors have developed a method that is effective in preventing and improving all kinds of skin roughness, and is also effective in terms of safety and stability. As a result of intensive research in order to obtain a substance that satisfies the needs of people, we found that when one or more selected from the group consisting of vitamin D3 and its derivatives are combined,
The present inventors have discovered that the present invention is extremely useful for preventing and improving all kinds of skin roughness, and have completed the present invention.
[問題点を解決するための手段1
すなわち、本発明は、ビタミンD3およびその誘導体か
らなる群より選ばれた一種又は二種以上を配合してな−
る皮膚化粧料である。[Means for Solving the Problems 1] That is, the present invention provides vitamin D3 containing one or more selected from the group consisting of vitamin D3 and derivatives thereof.
It is a skin cosmetic product.
次に本発明の構成について詳述する。Next, the configuration of the present invention will be explained in detail.
本発明に用いられるビタミンD3は別名コレカルシフェ
ロールであり、ビタミンD3m導体としては25−ヒド
ロキシコレカルシフェロール、1α−ヒドロキシコレカ
ルシフェロール、5.6−trans−25−ヒドロキ
シコレカルシフェロール、1α−25−ジヒドロキシコ
レカルシフェロール、ジヒドロタキステロール等が挙げ
られる。Vitamin D3 used in the present invention is also known as cholecalciferol, and vitamin D3m conductors include 25-hydroxycholecalciferol, 1α-hydroxycholecalciferol, 5.6-trans-25-hydroxycholecalciferol, 1α-25 -Dihydroxycholecalciferol, dihydrotachysterol and the like.
これ等、ビタミンD3又はその誘導体は全て白色の結晶
であって無臭である。また、これ等はエタノール、クロ
ロホルムなどの有機溶媒に溶けやすく、脂肪油にやや溶
けやすく、水にはほとんど溶けない物質である。These vitamin D3 or its derivatives are all white crystals and odorless. In addition, these substances are easily soluble in organic solvents such as ethanol and chloroform, slightly soluble in fatty oils, and almost insoluble in water.
かかるビタミンD3又はその誘導体の皮膚化粧料への配
合量は当該化粧料全量に対して、特に限定はされないが
、通常は0.000001〜5重量%、好ましくは0.
0005〜0.1重量%程度である。o、oo。The amount of vitamin D3 or its derivatives incorporated into skin cosmetics is not particularly limited, but is usually 0.000001 to 5% by weight, preferably 0.000001 to 5% by weight, based on the total amount of the cosmetics.
It is about 0.0005 to 0.1% by weight. o, oo.
001重量%未満では、肌あれの防止及び改善効果が乏
しくなる傾向があり、逆に5重量%をこえて配合しても
効果の大きな増加は望めない。If the amount is less than 0.001% by weight, the effect of preventing and improving skin roughness tends to be poor, and conversely, if the amount exceeds 5% by weight, no significant increase in the effect can be expected.
また、これ等ビタミンD3またはその誘導体は、197
1年にDeLucaら及びKodicekらによりほぼ
同時に発見されたもので、現在は医薬品としてビタミン
D代謝異常に伴う諸症状(低カリウム血症・テタニー・
骨癌・骨病変等)の改善に使用されている物質である。In addition, these vitamin D3 or its derivatives are 197
It was discovered almost simultaneously by DeLuca et al. and Kodicek et al.
This substance is used to improve bone cancer, bone lesions, etc.).
しかし、これ等ビタミンD3及びその誘導体の使用は全
て内服剤としての医薬品であって、外用としての使用例
は全く認められないものである。However, all of these uses of vitamin D3 and its derivatives are in the form of internal medicines, and no examples of external use have been observed.
本発明の皮膚化粧料には、上記した必須成分の他、一般
の皮膚化粧料に配合される通常の成分、例えば、油分、
水、界面活性剤、保湿剤、低級アルコール、増粘剤、キ
レート剤、色素、防腐剤、香料等を必要に応じて適宜配
合することができる。In addition to the above-mentioned essential ingredients, the skin cosmetics of the present invention include common ingredients that are included in general skin cosmetics, such as oil,
Water, surfactants, humectants, lower alcohols, thickeners, chelating agents, pigments, preservatives, fragrances, and the like can be added as appropriate.
本発明に於ける皮膚化粧料とは、皮膚に使用するものを
広く指し、例えば、化粧水、乳液、クリーム、パック等
のフエーシャル化粧料やファンデーション等を言う。The term "skin cosmetics" as used in the present invention broadly refers to products used on the skin, such as facial cosmetics such as lotions, milky lotions, creams, and packs, and foundations.
[実施例]
次に実験例及び実施例を挙げて本発明を更に詳細に説明
する。本発明はこれにより限定されるものでは勿論ない
。配合量は重量%である。[Example] Next, the present invention will be explained in further detail by giving experimental examples and examples. Of course, the present invention is not limited to this. The blending amount is in weight%.
実験例1 クリーム 表1に記載きれているC相を加熱し、70℃に保った。Experimental example 1 Cream Phase C, as listed in Table 1, was heated and maintained at 70°C.
これにA相、B相を順次加え予備乳化後ホモミキサーで
均一に乳化し、次いで徐冷してクリーム(試料NQI〜
Nc+5)を調製した。Phase A and phase B were added to this in sequence and pre-emulsified, then uniformly emulsified using a homomixer, and then gradually cooled to create a cream (sample NQI~
Nc+5) was prepared.
表1の各クリーム(試料Nα1〜NQ 4)をパネル(
22〜32才の女性)5名の顔の右半分に、試料Nα5
のクリームを顔の左半分に一日2回、連続2ケ月間塗布
した。Each cream in Table 1 (sample Nα1 to NQ 4) was applied to a panel (
Sample Nα5 was applied to the right half of the face of 5 women (22 to 32 years old).
The cream was applied to the left half of the face twice a day for two consecutive months.
試験終了後に顔の左右両方の塗布部の肌を皮膚インピー
ダンスとレプリカ法により測定し、皮膚のしっとり感と
皮膚のきめのこまやかきを較察した。After the test was completed, the skin at the application sites on both the left and right sides of the face was measured using skin impedance and a replica method, and the moist feeling of the skin and the fineness and roughness of the skin texture were compared.
(以下余白)
皮膚インピーダンスは、増田等の考案した高周波による
抵抗容量測定装置を用いた。これは3.5MH2の高周
波電流発生装置と抵抗、容量の検出計を一緒に含んだ本
体部、それに1cmの長ざのコード、その先端に付帯し
た円筒状電極からなっている装置である。電極は同心円
状で直径1mmの中心電極と1.5mmの距離にある内
径4mmの外周電極よりなっていて、電極を皮膚に当て
ると高周波がそれを介して流れるが、数μへの単位のも
のなのでパネルは何の不快感も感じない。この電極を被
検部に軽く触れると、1秒以内に一定値まで抵抗が急上
昇する。(Left below) Skin impedance was measured using a high-frequency resistance-capacitance measuring device devised by Masuda et al. This device consists of a main body that includes a 3.5 MH2 high frequency current generator and a resistance and capacitance detector, a 1 cm long cord, and a cylindrical electrode attached to the tip. The electrodes are concentric and consist of a center electrode with a diameter of 1 mm and an outer electrode with an inner diameter of 4 mm placed at a distance of 1.5 mm. When the electrodes are applied to the skin, high frequency waves flow through them, but the frequency is in the range of several microns. So I don't feel any discomfort from the panel. When this electrode is lightly touched on the area to be tested, the resistance rises rapidly to a certain value within one second.
この抵抗の逆数はコンダクタンス(Conduct−a
nce )と呼ばれ単位はμΩであられせられる。この
コンダクタンスは皮膚表面の水含量とほぼ比例関係にあ
り、更に皮膚は水分含量の多いほど皮膚のしっとり感は
良いと判断されることから、コンダクタンスの増加で皮
膚のしっとり感を評価することにした。The reciprocal of this resistance is the conductance (Conduct-a
nce), and its unit is μΩ. This conductance is almost proportional to the water content on the skin surface, and the higher the water content of the skin, the better the moist feeling of the skin, so we decided to evaluate the moist feeling of the skin by increasing the conductance. .
表2はNa2のクリームを使用したパネルの顔面での皮
膚インピーダンスにおけるコンダクタンスを、階5のク
リームの使用パネルの顔面使用部位と比較したものであ
る。Table 2 compares the conductance in the skin impedance on the face of the panel using the Na2 cream with the facial area of the panel using the floor 5 cream.
1α−25−ジヒドロキシコレカルシフェロールを10
−4重量%添加したクリームを使用したパネルの使用部
位(右顔面)のコンダクタンスは上記薬剤無添加のクリ
ーム(Na5)を使用したパネルの顔面での使用部位よ
りも、有意に高い数値として得られることがわかった。1α-25-dihydroxycholecalciferol 10
- The conductance of the application site (right face) of the panel using the cream containing 4% by weight is significantly higher than that of the application site of the panel using the above drug-free cream (Na5). I understand.
そしてこのことは皮膚に対して、よりしっとり感を与え
たクリームは前述に従えば、Na 2であることを示し
ている。This shows that the cream that gave the skin a more moisturized feel was Na 2 according to the above.
同様にして全パネルのコンダクタンスを測定した。The conductance of all panels was measured in the same manner.
1α−25−ジヒドロキシコレカルシフェロールを添加
したクリームを使用したパネルの右顔面のコンダクタン
スと、Na5のクリームを使用した左顔面のコンダクタ
ンスを比較し、右側の方が70%以上上昇した場合を著
しく効果あり、50%以上70%未満上昇した場合をや
や効果あり、50%以下の場合を効果なしと判定し、そ
の結果を表3に示した。Compare the conductance of the right face of the panel using the cream containing 1α-25-dihydroxycholecalciferol and the conductance of the left face using the Na5 cream, and if the conductance on the right side increases by 70% or more, it is considered to be significantly effective. The results are shown in Table 3.The results are shown in Table 3.The results are shown in Table 3.
表3 一方、皮膚のきめの細やかきはレプリカ法で観察した。Table 3 On the other hand, the fineness of the skin texture was observed using the replica method.
シリコンラバーを皮膚に密着させて皮膚の表面像をとり
、ついでこのシリコンラバーに工ボキシ樹脂を流し込み
反転像を得た。この反転像の表面に表面粗ざ試験器を操
作させて皮膚状態を調べた。そして皮膚表面の起伏の大
きいほど、皮膚のきめが細やかであると判定した。A silicone rubber was brought into close contact with the skin to take a surface image of the skin, and then engineered boxy resin was poured into the silicone rubber to obtain an inverted image. A surface roughness tester was operated on the surface of this inverted image to examine the skin condition. It was determined that the greater the undulations of the skin surface, the finer the skin texture.
同様にして全パネルの顔面のレプリカ像をとり顔面の左
右を比較し、明らかに右顔面の方が起伏が大きかった場
合を効果ありと判定し、明白な差の認められなかった場
合を効果なしと判定し、その結果を表3にまとめた。In the same way, replica images of the faces of all panels were taken and the left and right sides of the face were compared. If the right side of the face had clearly larger undulations, it was determined that there was an effect, and if there was no obvious difference, it was determined that there was no effect. The results are summarized in Table 3.
クリームに添加した1α−25−ジヒドロキシコレカル
シフェロールは添加濃度にほぼ比例して、皮膚のしっと
り感・きめの細やかざの改善に対して優れた効果を発揮
することが認められた。It was found that 1α-25-dihydroxycholecalciferol added to the cream had an excellent effect on improving the moist feeling, fine texture, and texture of the skin in approximately proportion to the concentration added.
以下に本発明の実施例を示す。Examples of the present invention are shown below.
実施例1
95%エチルアルコール8gにポリビニルピロリドン0
.05g、オレイルアルコール0.1g、ポリオキシエ
チレンモノオレート1.2g、 1α−ヒドロキシコレ
カルシフェロール0.001g1香料0.2g1パラオ
キシ安息香酸メチルエステル0.1g1少量の酸化防止
剤、少量の色素を混合溶解した。これをグリセリン5g
を精製水85.349gに溶解したものの中に撹拌添加
して肌あれの改善効果のある化粧水を得た
実施例2
セチルアルコール1.2g−、スフ99210g1ワセ
リン2gs 5.6−trans−25−ヒドロキシコ
レカルシフェロール0.1g1パラオキシ安息香酸エチ
ルエステル0.2g、グリセリンモノステアレート1g
1ポリオキシエチレン(20モル付加)モノステアレー
トIg、ポリオキシエチレン(20モル付加)モノオレ
ート1g及び香料0.1gを70℃で加温混合溶解し、
同様にジプロピレングリコール5gsポリエチレングリ
コール15002g、 トリエタノールアミン0.2
g1精製水76.2gを75℃で加熱溶解させた。両者
を混合して乳化し、ホモジナイザーにより乳化粒子を整
えて冷却してW2O型の肌あれ改善効果のある乳液をえ
た。Example 1 8 g of 95% ethyl alcohol and 0 polyvinylpyrrolidone
.. 0.5g, oleyl alcohol 0.1g, polyoxyethylene monooleate 1.2g, 1α-hydroxycholecalciferol 0.001g1 fragrance 0.2g1 paraoxybenzoic acid methyl ester 0.1g1 a small amount of antioxidant, a small amount of pigment mixed and dissolved. did. Add this to 5g of glycerin
Example 2 A lotion with the effect of improving rough skin was obtained by stirring and adding the following ingredients to a solution dissolved in 85.349 g of purified water. Example 2: Cetyl alcohol 1.2 g, Sufu 99210 g 1 Vaseline 2 gs 5.6-trans-25- Hydroxycholecalciferol 0.1g 1 paraoxybenzoic acid ethyl ester 0.2g, glycerin monostearate 1g
1 Ig of polyoxyethylene (20 mol addition) monostearate, 1 g of polyoxyethylene (20 mol addition) monooleate, and 0.1 g of fragrance were heated and mixed and dissolved at 70°C,
Similarly, dipropylene glycol 5gs polyethylene glycol 15002g, triethanolamine 0.2
g1 76.2 g of purified water was heated and dissolved at 75°C. Both were mixed and emulsified, and the emulsified particles were prepared using a homogenizer and cooled to obtain a W2O type emulsion having an effect on improving rough skin.
実施例3
ジプロピレングリコール5g1トリエタノールアミン0
.5g、粉末着色料10g1香料0.1g、パラオキシ
安息香酸エチルエステル0.2g、少量の酸化防止剤及
び精製水60.699995gを混合し、均一に分散さ
せて75℃に加熱した。この中へステアリン酸1.2g
、セチルアルコール0.3g、流動パラフィン20g1
ポリオキシエチレンオレイン酸エステル2g、 25−
ヒドロキシコレカルシフェノール0.000001gを
混合融解し75℃に保ったものを徐々に添加し反応乳化
を行い、冷却しながら攪拌して肌あれ防止効果のあるフ
ァンデーションを得た。Example 3 Dipropylene glycol 5g 1 triethanolamine 0
.. 5g of powder coloring, 10g of powder coloring, 0.1g of fragrance, 0.2g of paraoxybenzoic acid ethyl ester, a small amount of antioxidant, and 60.699995g of purified water were mixed, uniformly dispersed, and heated to 75°C. Stearic acid 1.2g into this
, cetyl alcohol 0.3g, liquid paraffin 20g1
Polyoxyethylene oleate ester 2g, 25-
A mixture of 0.000001 g of hydroxycholecalciphenol was mixed and melted and kept at 75° C. to perform reaction emulsification, and the mixture was stirred while cooling to obtain a foundation having an effect of preventing rough skin.
実施例4
95%エチルアルコール8gに1.3−ブチレングリコ
ール5g1ポリオキシエチレン(20モル付加)モノオ
レート1.5g、コレカルシフェロール0.0005g
1パラオキシ安息香酸エチルエステル0.2gs香料0
.1g、少量の色素を混合溶解し、ポリビニルアルコー
ル10g1ポリエチレングリコール20001gおよび
精製水74.1995gを80℃で混合溶解した中に攪
拌添加し、室温まで冷却して肌あれ防止効果のある乾燥
皮膜型パックを得た。Example 4 8 g of 95% ethyl alcohol, 5 g of 1.3-butylene glycol, 1.5 g of polyoxyethylene (20 mol addition) monooleate, 0.0005 g of cholecalciferol
1 paraoxybenzoic acid ethyl ester 0.2gs fragrance 0
.. 1g of pigment is mixed and dissolved, 10g of polyvinyl alcohol, 20001g of polyethylene glycol, and 74.1995g of purified water are mixed and dissolved at 80℃, and the mixture is stirred and added, and the mixture is cooled to room temperature to create a dry film-type pack that has the effect of preventing rough skin. I got it.
実施例5
95%エチルアルコール5gにポリオキシエチレンソル
ビタンモノオレート1.2g、アルギン酸ナトリウム0
.1g、コンドロイチン硫酸ナトリウム0.2g、ヒア
ルロン酸0.1g、ビタミンEアセート0.1g、グリ
チルリチン酸モノアンモニウム塩0.1g1パラオキシ
安息香酸メチルエステル0.1g125−ヒドロキシコ
レカルシフェロール0.00005g1及び適量の色素
を混合し、これをグリセリン5g及び精製水88.09
995gを混合溶解した中へ攪拌添加して肌あれ防止効
果のある美容液を得た。Example 5 5 g of 95% ethyl alcohol, 1.2 g of polyoxyethylene sorbitan monooleate, 0 sodium alginate
.. 1g, sodium chondroitin sulfate 0.2g, hyaluronic acid 0.1g, vitamin E acetate 0.1g, glycyrrhizic acid monoammonium salt 0.1g1, paraoxybenzoic acid methyl ester 0.1g1, 25-hydroxycholecalciferol 0.00005g1, and an appropriate amount of pigment. Mix this with 5g of glycerin and 88.09g of purified water.
995g was mixed and added to the mixture with stirring to obtain a beauty serum having an effect of preventing rough skin.
Claims (1)
た一種又は二種以上を配合したことを特徴とする皮膚化
粧料。A skin cosmetic containing one or more selected from the group consisting of vitamin D_3 and its derivatives.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1124686A JPS62169711A (en) | 1986-01-22 | 1986-01-22 | Skin cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1124686A JPS62169711A (en) | 1986-01-22 | 1986-01-22 | Skin cosmetic |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS62169711A true JPS62169711A (en) | 1987-07-25 |
Family
ID=11772582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1124686A Pending JPS62169711A (en) | 1986-01-22 | 1986-01-22 | Skin cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS62169711A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5185150A (en) * | 1990-08-24 | 1993-02-09 | Wisconsin Alumni Research Fdn. | Cosmetic compositions containing 19-nor-vitamin D compounds |
US5276061A (en) * | 1990-08-24 | 1994-01-04 | Wisconsin Alumni Research Foundation | Cosmetic compositions containing 1α-hydroxyvitamin D homologs |
US5366731A (en) * | 1990-08-24 | 1994-11-22 | Wisconsin Alumni Research Foundation | Cosmetic compositions containing secosterol compounds |
US5459136A (en) * | 1990-08-24 | 1995-10-17 | Wisconsin Alumni Research Foundation | Methods using vitamin D compounds for improvement of skin conditions |
KR100450435B1 (en) * | 1996-10-22 | 2004-11-20 | 주식회사 엘지생활건강 | Cosmetic composition containing cholecalciferol which inhibits cell proliferation and induces normal cornification, wherein the composition prevents abnormal excessive cornification and reduces wrinkles |
JP2005522463A (en) * | 2002-03-13 | 2005-07-28 | コッラジェネックス ファーマシューチカルス インコーポレイテッド | Water based delivery system |
JP2007516236A (en) * | 2003-11-13 | 2007-06-21 | ザ プロクター アンド ギャンブル カンパニー | Hairless protein interaction partner complex and method for beautifying and / or improving mammalian skin |
JP2014159389A (en) * | 2013-02-20 | 2014-09-04 | Seiren Co Ltd | Filaggrin production promoter and external preparation for skin |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5910506A (en) * | 1982-07-09 | 1984-01-20 | Lion Corp | Cosmetic composition |
JPS61152615A (en) * | 1984-12-26 | 1986-07-11 | Lion Corp | Cosmetic composition |
JPS61183206A (en) * | 1985-02-09 | 1986-08-15 | Lion Corp | Cell-activating agent |
JPS62106837A (en) * | 1984-12-03 | 1987-05-18 | Takeda Chem Ind Ltd | Emulsion composition |
JPS62149629A (en) * | 1985-09-05 | 1987-07-03 | Kazumi Ogata | Humectant skin agent |
-
1986
- 1986-01-22 JP JP1124686A patent/JPS62169711A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5910506A (en) * | 1982-07-09 | 1984-01-20 | Lion Corp | Cosmetic composition |
JPS62106837A (en) * | 1984-12-03 | 1987-05-18 | Takeda Chem Ind Ltd | Emulsion composition |
JPS61152615A (en) * | 1984-12-26 | 1986-07-11 | Lion Corp | Cosmetic composition |
JPS61183206A (en) * | 1985-02-09 | 1986-08-15 | Lion Corp | Cell-activating agent |
JPS62149629A (en) * | 1985-09-05 | 1987-07-03 | Kazumi Ogata | Humectant skin agent |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5654292A (en) * | 1990-08-24 | 1997-08-05 | Wisconsin Alumni Research Foundation | Methods and compositions containing vitamin D compounds for improvement of skin conditions |
US5276061A (en) * | 1990-08-24 | 1994-01-04 | Wisconsin Alumni Research Foundation | Cosmetic compositions containing 1α-hydroxyvitamin D homologs |
US5366731A (en) * | 1990-08-24 | 1994-11-22 | Wisconsin Alumni Research Foundation | Cosmetic compositions containing secosterol compounds |
US5459136A (en) * | 1990-08-24 | 1995-10-17 | Wisconsin Alumni Research Foundation | Methods using vitamin D compounds for improvement of skin conditions |
US5578587A (en) * | 1990-08-24 | 1996-11-26 | Wisconsin Alumni Research Foundation | Methods and compositions containing vitamin D compounds for improvement of skin conditions |
US5612326A (en) * | 1990-08-24 | 1997-03-18 | Wisconsin Alumni Research Foundation | Methods containing vitamin D compounds for improvement of skin conditions |
US5185150A (en) * | 1990-08-24 | 1993-02-09 | Wisconsin Alumni Research Fdn. | Cosmetic compositions containing 19-nor-vitamin D compounds |
KR100450435B1 (en) * | 1996-10-22 | 2004-11-20 | 주식회사 엘지생활건강 | Cosmetic composition containing cholecalciferol which inhibits cell proliferation and induces normal cornification, wherein the composition prevents abnormal excessive cornification and reduces wrinkles |
JP2005522463A (en) * | 2002-03-13 | 2005-07-28 | コッラジェネックス ファーマシューチカルス インコーポレイテッド | Water based delivery system |
KR101076335B1 (en) * | 2002-03-13 | 2011-10-26 | 토마스 스쾰트 | Water-based delivery systems |
JP4806519B2 (en) * | 2002-03-13 | 2011-11-02 | トマス スコルド | Water based delivery system |
JP2007516236A (en) * | 2003-11-13 | 2007-06-21 | ザ プロクター アンド ギャンブル カンパニー | Hairless protein interaction partner complex and method for beautifying and / or improving mammalian skin |
JP2014159389A (en) * | 2013-02-20 | 2014-09-04 | Seiren Co Ltd | Filaggrin production promoter and external preparation for skin |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2125443C1 (en) | Cosmetic or dermatological composition for simultaneous treatment of surface and deep layers of skin and its application | |
JPS63275506A (en) | Skin cosmetic | |
Aktar et al. | Skin depigmentation activity of Crocus sativus extract cream | |
JP2005082600A (en) | Method for treating skin condition | |
JPS62169711A (en) | Skin cosmetic | |
JP2775154B2 (en) | Anti-skin and anti-aging agents | |
JP3817114B2 (en) | Antioxidant and external preparation for skin containing the same | |
JPH08259433A (en) | Cosmetic or preparation for external use containing humectant composition | |
CN110227039A (en) | With the cosmetic composition from frothing function | |
JPS624362B2 (en) | ||
JPH0533926B2 (en) | ||
JP2549119B2 (en) | Topical | |
JPH08183726A (en) | Skin preparation for external use | |
JP2000247987A (en) | Highly hydrogenated lecithin | |
JP2001278783A (en) | Collagen production promoter | |
JPH0687730A (en) | Cosmetic | |
CN109589280A (en) | A kind of moisturising preparations and preparation method thereof | |
JP2004075572A (en) | Skin elasticity ameliorant and external preparation for skin | |
JP2644531B2 (en) | Cosmetics | |
JPS61205204A (en) | External preparation for skin | |
JPH0296581A (en) | Biotin ester and skin ointment and hair tonic using the ester | |
JPH11246385A (en) | Antiaging agent | |
JPH0977655A (en) | Skin preparation for external use | |
JP2854767B2 (en) | Thickening gelling agent | |
JPH082772B2 (en) | Sebum secretagogue |